Displaying items 13-24 of 202
» View courant.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-17
•
Next >
-
XenoPort to drop multiple sclerosis drug, shares fall
Reuters(Reuters) - XenoPort Inc said it would stop development of an experimental multiple sclerosis treatment it planned to launch in 2015 after a late-stage trial failed to show significant improvement over a placebo. Shares of the company fell 26 percent...Tags: Conservation, Stock Activities, Acorda Therapeutics Incorporated, New Products, Multiple Sclerosis
-
Royalty raises Elan bid, issues ultimatum to shareholders
ReutersDUBLIN/NEW YORK (Reuters) - Royalty Pharma raised its hostile bid for Elan to $12.50 per share and threatened to withdraw the bid if Elan shareholders approve a series of defensive transactions announced by the Irish drug firm. Royalty Pharma, which buys...Tags: Stock Activities, Theravance Incorporated, Economy, Business and Finance, Multiple Sclerosis, Companies and Corporations
-
Pointing to threat, pulling in profit
Tribune Washington BureauWASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...Tags: Politics, Bioterrorism, Rockville (Bethlehem, Pennsylvania), Terrorism, U.S. Department of Homeland Security
-
Timeline: An attorney and anthrax
May 2001: Washington lawyer Richard J. Danzig is appointed to the board of Human Genome Sciences Inc. in Rockville, Md. Sept. 11, 2001: Terrorists crash passenger jets into the World Trade Center in New York, the Pentagon and rural Pennsylvania. Soon...Tags: Rockville (Bethlehem, Pennsylvania), Anthrax, U.S. Congress, Human Genome Sciences Inc.
-
Spotlighting a terrorism risk, and profiting
WASHINGTON — Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...
Tags: Politics, Bioterrorism, Rockville (Bethlehem, Pennsylvania), Terrorism, U.S. Department of Homeland Security
-
Chief executives and the itch to quit
ReutersBy Andrew Callus LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds". A handful of recent shock departures by 50-something chief executives at...Tags: Science and Technology, Belgium, Diageo Plc, Delhaize Group, Corporate Officers
-
Elan says Royalty wanted to take it private before Tysabri deal
ReutersDUBLIN, May 15 (Reuters) - Royalty Pharma last year urged Elan to hold off on a multi-billion dollar drug deal until it had taken the Irish drugmaker private to boost the compensation the firms' executives would receive, Elan said on Wednesday. Royalty...Tags: Companies and Corporations, Elan Corporation Plc, Theravance Incorporated, CEO Pay, Economy, Business and Finance
-
Supreme Court to rule on attorney general's use of private counsel
Charleston Daily Mail, W.Va.CHARLESTON, W.Va. -- The state Supreme Court soon will decide whether the Attorney General's Office is allowed to hire outside attorneys to help litigate cases. The decision follows a lengthy legal battle stemming from consumer protection disputes...Tags: Lawyers, Credit and Debt, Healthcare Industry, Oral and Maxillofacial Surgeons, Citigroup Incorporated
-
REUTERS SUMMIT-Drug industry CEOs plotting more carve-outs
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * New generation of CEOs more open to restructuring * Established drug products in focus at Pfizer, GSK, Sanofi * Bankers see divestments helping to unlock...Tags: HIV, Restructuring and Recapitalization, Abbott Laboratories, Banking, Companies and Corporations
-
Wall St termina plano tras recientes máximos
ReutersPor Caroline Valetkevitch NUEVA YORK (Reuters) - Las acciones cerraron planas el lunes en la bolsa de Nueva York, tomándose un respiro tras trepar a máximos históricos la semana pasada, pero la fortaleza del sector cuidado de la salud ayudó a que los...Tags: Nasdaq Composite, Elan Corporation Plc, S&P 500, Financial Markets, Theravance Incorporated
-
FACTBOX-Vaccine, drugs to fight new bird flu
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) May 6 (Reuters) - The U.N. World Health Organization and the U.S. Centers for Disease Control and Prevention are already working with samples of the new H7N9...Tags: Preventative Medicine, Australia, Pharmaceuticals, Flu Vaccine, Disease Prevention
-
Elan alcanza acuerdo por regalÃas de 1.000 mln dlrs con Theravance
ReutersPor Padraic Halpin DUBLIN (Reuters) - Elan intensificó el lunes su intento por mantener su independencia al alcanzar un acuerdo de 1.000 millones de dólares para comprar el 21 por ciento de las regalÃas que la firma estadounidense Theravance recibe de...Tags: Elan Corporation Plc, Theravance Incorporated, Biogen Idec Incorporated
May 20, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 19, 2013
|Story| Los Angeles Times
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| McClatchy-Tribune
May 7, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
May 6, 2013
|Story| Reuters
May 13, 2013
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.
